Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Momenta Pharma (MNTA)

Momenta Pharma (MNTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,666,751
  • Shares Outstanding, K 98,917
  • Annual Sales, $ 75,590 K
  • Annual Income, $ -176,060 K
  • 60-Month Beta 2.07
  • Price/Sales 21.71
  • Price/Cash Flow N/A
  • Price/Book 5.95

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.59
  • Number of Estimates 5
  • High Estimate -0.47
  • Low Estimate -0.81
  • Prior Year -0.07
  • Growth Rate Est. (year over year) -742.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.13 +17.51%
on 11/18/19
17.85 -0.39%
on 12/06/19
+2.13 (+13.61%)
since 11/06/19
3-Month
12.21 +45.62%
on 10/02/19
17.85 -0.39%
on 12/06/19
+4.99 (+39.01%)
since 09/06/19
52-Week
9.51 +86.96%
on 07/22/19
17.85 -0.39%
on 12/06/19
+5.70 (+47.19%)
since 12/06/18

Most Recent Stories

More News
Look for Shares of Momenta Pharmace to Potentially Pullback after Yesterday's 3.69% Rise

Momenta Pharmace (NASDAQ:MNTA) traded in a range yesterday that spanned from a low of $16.51 to a high of $17.23. Yesterday, the shares gained 3.7%, which took the trading range above the 3-day high...

MNTA : 17.86 (+5.99%)
Momenta Pharmaceuticals Announces Poster Presentation at the 61st American Society of Hematology Annual Meeting and Exposition

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) today announced that Santiago Arroyo, M.D., Ph.D., Chief Medical Officer, will deliver a poster presentation at the upcoming 61 American Society of Hematology...

MNTA : 17.86 (+5.99%)
Myriad Genetics has the Best Relative Performance in the Biotechnology Industry (MYGN , MNTA , BPMC , ICPT , TGTX )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

BPMC : 77.25 (+3.61%)
MNTA : 17.86 (+5.99%)
MYGN : 25.68 (+0.04%)
Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today announced that it will...

MNTA : 17.86 (+5.99%)
Momenta Pharmaceuticals (MNTA) Reports Q3 Loss, Tops Revenue Estimates

Momenta (MNTA) delivered earnings and revenue surprises of -14.29% and 39.06%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

MNTA : 17.86 (+5.99%)
Momenta: 3Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Momenta Pharmaceuticals Inc. (MNTA) on Thursday reported a loss of $44.5 million in its third quarter.

MNTA : 17.86 (+5.99%)
Momenta Pharmaceuticals Reports Third Quarter 2019 Financial and Operating Results

Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today reported its financial...

MNTA : 17.86 (+5.99%)
Hospitals, Third-Party Payors, and People Who Bought or Provided Reimbursement for the Anticoagulant Medications Lovenox® or Generic Enoxaparin, Could Be Included in a Class Action Lawsuit

The following is being released by Lieff Cabraser Heimann & Bernstein, LLP.

MNTA : 17.86 (+5.99%)
Momenta Pharmaceuticals Announces Date of Third Quarter 2019 Financial Results Conference Call and Webcast

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today announced that it will...

MNTA : 17.86 (+5.99%)
Momenta Pharmace Shares Up 20.6% Since SmarTrend's Buy Recommendation (MNTA)

SmarTrend identified an Uptrend for Momenta Pharmace (NASDAQ:MNTA) on July 31st, 2019 at $11.41. In approximately 2 months, Momenta Pharmace has returned 20.60% as of today's recent price of $13.76.

MNTA : 17.86 (+5.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Trade MNTA with:

Business Summary

Momenta Pharmaceuticals is a leader in the analysis, characterization and design of complex pharmaceutical products. Their scientific foundation is a set of tools and methods that allow them to develop a deep understanding of the links between a compound's chemical structure, biological function and...

See More

Key Turning Points

2nd Resistance Point 17.32
1st Resistance Point 17.09
Last Price 17.86
1st Support Level 16.51
2nd Support Level 16.17

See More

Last Price 17.86
52-Week High 17.85
Fibonacci 61.8% 14.66
Fibonacci 50% 13.68
Fibonacci 38.2% 12.70
52-Week Low 9.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar